Molecular diagnosis is performed at the gene level with nucleic acids as the object for detection, with high sensitivity and accuracy.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Promega said on Thursday that it has signed a license agreement for MilliporeSigma's foundational CRISPR genome editing technology.

Curetis said after the close of the market on Friday that the US Food and Drug Administration has cleared the company's Unyvero LRT lower respiratory tract application cartridge for marketing in the US.

Molecular diagnostics firm ChromaCode said on Tuesday that it has raised $28 million in Series C financing.

Bio-Rad Laboratories disclosed in a Form 8-K filed with the US Securities and Exchange Commission on Friday that it was the victim of a ransomware attack on its network the day before.

Roche Licenses Codexis DNA Ligase Enzyme for NGS Library Prep Kits

Roche announced Monday the launch of its Cobas Zika test in countries that accept the CE mark.

Qiagen announced earlier this week that it has completed a strategic review, and after receiving interest from unnamed parties, the firm has decided to remain a stand-alone business.

Roche said on Tuesday it has commenced a tender offer to purchase for cash a combined aggregate purchase price of up to $2 billion of certain notes.

Qiagen said on Friday afternoon that it has received several "conditional, non-binding indications of interest" from potential merger or acquisition partners.

A consortium led by private equity firms Cinven and Astorg said on Thursday that it has signed an agreement to acquire life science tools company LGC for an undisclosed amount, subject to regulatory approval and other customary clearances.